安飞士(CAR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CAR 安飞士

盘前交易 11-22 09:27:15 EST

101.64

+2.58

+2.60%

盘前101.75

+0.11+0.11%

08:48 EST

最高104.45	最低98.63	成交量50.65万
今开99.25	昨收99.06	日振幅5.88%
总市值35.72亿	流通市值17.21亿	总股本3,514万
成交额5,185万	换手率2.99%	流通股本1,693万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CAR","market":"US","secType":"STK","nameCN":"安飞士","latestPrice":101.64,"timestamp":1732222800000,"preClose":99.06,"halted":0,"volume":506521,"hourTrading":{"tag":"盘前","latestPrice":101.75,"preClose":101.64,"latestTime":"08:48 EST","volume":1387,"amount":141242.27391000002,"timestamp":1732283296111},"delay":0,"floatShares":16927985,"shares":35139198,"eps":11.079278,"marketStatus":"盘前交易","marketStatusCode":1,"change":2.58,"latestTime":"11-22 09:27:15 EST","open":99.25,"high":104.45,"low":98.63,"amount":51854565.65837,"amplitude":0.058752,"askPrice":102.5,"askSize":73,"bidPrice":100,"bidSize":2,"shortable":3,"etf":0,"ttmEps":11.079278,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732285800000},"adr":0,"adjPreClose":101.64,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":101.75,"preClose":101.64,"latestTime":"08:48 EST","volume":1387,"amount":141242.27391000002,"timestamp":1732283296111},"postHourTrading":{"tag":"盘后","latestPrice":101.64,"preClose":101.64,"latestTime":"16:05 EST","volume":9150,"amount":930004.6,"timestamp":1732223111245},"volumeRatio":0.7785602167390595,"impliedVol":0.6,"impliedVolPercentile":0.4622},"requestUrl":"/m/hq/s/CAR/tweets","defaultTab":"tweets","newsList":[{"id":"2485268350","title":"汽车租赁股明年前景堪忧 大摩下调赫兹(HTZ.US)和安飞士(CAR.US)目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=2485268350","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485268350?lang=zh_cn&edition=full","pubTime":"2024-11-22 21:13","pubTimestamp":1732281217,"startTime":"0","endTime":"0","summary":"Jonas强调：“我们认为，随着第三季度飓风的影响消退，以及Enterprise继续更新车队以使其在机场更具竞争力，市场竞争日益加剧，2025财年的定价不确定性可能会继续上升。机场占赫兹租车和安飞士客运量的66%以上。”摩根士丹利予赫兹“持有”评级，目标价从7美元下调至3美元;予安飞士“增持”评级，但将目标价从160美元下调至120美元。今年以来，赫兹股价下跌了63%，安飞士股价下跌了45%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1214942.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HTZ","CAR"],"gpt_icon":0},{"id":"2485057281","title":"全球碳市场渐近，还有哪些障碍？","url":"https://stock-news.laohu8.com/highlight/detail?id=2485057281","media":"虎嗅APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485057281?lang=zh_cn&edition=full","pubTime":"2024-11-22 15:03","pubTimestamp":1732259012,"startTime":"0","endTime":"0","summary":"本文来自微信公众号：环球零碳，作者：Yinyin，编辑：Tang，原文标题：《全球碳市场渐近，还有哪些障碍？对中国企业影响几何？》，题图来自：AI生成在阿塞拜疆召开的第29届联合国气候大会（COP29）关于全球碳市场的强势开局，让碳圈从业者兴奋了一阵。大家冷静下来发现，虽然全球碳市场的脚步越来越近，但与《巴黎协定》第...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/ONjQm-iiUVdPYnVMrMGdR0h-H9FDkz1f1CB0wbtLakAloAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/ONjQm-iiUVdPYnVMrMGdR0h-H9FDkz1f1CB0wbtLakAloAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241122A05OGE00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241122A05OGE00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["LU0106831901.USD","IE00B19Z3B42.SGD","ACR","LU2237443622.USD","LU2237443549.SGD","IE0004091025.USD","BK4550","IE00BFXG1179.USD","IE00B19Z3581.USD","BK4504","BK4127","BK4110","LU2237443382.USD","LU2237443465.HKD","LU2237438978.USD","IE0004086264.USD","IE00BSNM7G36.USD","BK4588","LU2237443895.HKD","CAR","IE0034235188.USD","IE0002270589.USD","BK4022","LU2237443978.SGD","BK4552","LU1791807156.HKD","BK4585","LU1668664300.SGD","BK4516","BK4230","BK4533"],"gpt_icon":0},{"id":"2485284881","title":"德国汽车工业能否恢复昔日荣光？","url":"https://stock-news.laohu8.com/highlight/detail?id=2485284881","media":"FTChinese","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485284881?lang=zh_cn&edition=full","pubTime":"2024-11-22 14:58","pubTimestamp":1732258680,"startTime":"0","endTime":"0","summary":"正处于十字路口的德国汽车行业既不愿丧失竞争力，也不愿趋于平庸，但要恢复昔日荣光并非易事。第三种情景是大众、宝马和其他汽车制造商能够恢复昔日荣光。然而，值得关注的是，德国汽车行业目前仍在与产能过剩作斗争。因而，德国汽车行业面临的形势十分严峻。他称，这是德国重新站起来的唯一途径，从而为德国汽车工业指明了发展方向。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.ftchinese.com/story/001104858?topnav=world&exclusive&archive","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"ftchinese_highlight","symbols":["BK4230","CAR","BK4022"],"gpt_icon":0},{"id":"2485976224","title":"安飞士涨0.95% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2485976224","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485976224?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:31","pubTimestamp":1732199460,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时31分，安飞士股票出现异动，股价大幅拉升0.95%。截至发稿，该股报100.00美元/股，成交量3113股，换手率0.01%，振幅0.00%。机构评级方面，在所有9家参与评级的机构中，56%的券商给予买入建议，44%的券商给予持有建议，无券商给予卖出建议。安飞士股票所在的租赁服务行业中，整体涨幅为0.00%。Avis 的服务对象为旅游业的高端商业和休闲分部，Budget 则面向重视性价比的客户。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121223100abd4e5fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121223100abd4e5fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4230","CAR","BK4022"],"gpt_icon":0},{"id":"2484765286","title":"安飞士跌2.72% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2484765286","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484765286?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:31","pubTimestamp":1731940265,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时31分，安飞士股票出现异动，股价急速下挫2.72%。截至发稿，该股报97.52美元/股，成交量1.4929万股，换手率0.04%，振幅0.67%。安飞士股票所在的租赁服务行业中，整体跌幅为0.03%。其相关个股中，Ftai Aviation Ltd.、Willscot Holdings Corporation、Alta Equipment Group Inc.涨幅较大，Zoomcar Holdings, Inc.、AerCap飞机租赁、安飞士较为活跃，换手率分别为0.26%、0.15%、0.04%，振幅较大的相关个股有Mcgrath Rentcorp、安飞士、AerCap飞机租赁，振幅分别为1.96%、0.67%、0.56%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822310595be4807&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822310595be4807&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4230","BK4022","CAR"],"gpt_icon":0},{"id":"2483658473","title":"通用型CAR-T疗法或解开百万元一针难题","url":"https://stock-news.laohu8.com/highlight/detail?id=2483658473","media":"中国经营报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483658473?lang=zh_cn&edition=full","pubTime":"2024-11-16 03:43","pubTimestamp":1731699791,"startTime":"0","endTime":"0","summary":"本报记者 陈婷 曹学平 深圳报道近些年，人们为细胞免疫疗法CAR-T展现出“一针见效”的神奇疗效所惊叹，同时对其动辄百万元一针的价格望而却步。市场普遍认为，被贴上“天价”标签的CAR-T疗法注定无法“飞入寻常百姓家”。但最近一款新药的研发进展让原本“注定”的局面泛起了波澜。近日，科济药业（2171.HK）公布异体双靶点...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241116A00VXZ00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241116A00VXZ00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK4230","CAR","BK4022"],"gpt_icon":0},{"id":"2483081586","title":"安飞士盘中异动 下午盘急速跳水5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483081586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483081586?lang=zh_cn&edition=full","pubTime":"2024-11-16 02:57","pubTimestamp":1731697053,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日02时57分，安飞士股票出现波动，股价急速下挫5.14%。截至发稿，该股报101.09美元/股，成交量18.1842万股，换手率0.52%，振幅6.00%。安飞士股票所在的租赁服务行业中，整体跌幅为1.28%。安飞士公司简介：Avis Budget Group Inc 是一家汽车租赁和汽车共享服务提供商。公司品牌包括 Avis、Budget 和 Zipcar。Avis 的服务对象为旅游业的高端商业和休闲分部，Budget 则面向重视性价比的客户。公司经营自有的租赁地网络，并向特许经营者授权其品牌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116025734abc564e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116025734abc564e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4230","BK4022","CAR"],"gpt_icon":0},{"id":"2483399873","title":"不打价格战，CAR-T疗法在美国","url":"https://stock-news.laohu8.com/highlight/detail?id=2483399873","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483399873?lang=zh_cn&edition=full","pubTime":"2024-11-15 11:20","pubTimestamp":1731640801,"startTime":"0","endTime":"0","summary":"前有诺华、吉利德两大巨头的CAR-T疗法获批多年，作为后来者的biotech，应该如何定价？上周五， Autolus靶向CD19抗原的自体CAR-T疗法Aucatzyl获FDA批准上市，用于治疗复发性/难治性成人B细胞急性淋巴细胞白血病的成人患者。国产CAR-T疗法跌破百万，美国却不打价格战。CD19是CAR-T疗法中最成功的靶点，目前已批准上市的CAR-T疗法中，大部分针对CD19。而这些差异化选手，也必然会让市场对CAR-T疗法更乐观。CAR-T疗法的疗效有目共睹，但目前仍有许多不足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/244693","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["CAR","BK4022","BK4230"],"gpt_icon":0},{"id":"2483547770","title":"安飞士涨3.38% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2483547770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483547770?lang=zh_cn&edition=full","pubTime":"2024-11-13 04:49","pubTimestamp":1731444565,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日04时49分，安飞士股票出现波动，股价快速上涨3.38%。截至发稿，该股报100.10美元/股，成交量51.7885万股，换手率1.47%，振幅7.72%。最近的财报数据显示，该股实现营业收入34.80亿美元，净利润2.37亿美元，每股收益6.68美元，毛利11.24亿美元，市盈率8.87倍。安飞士股票所在的租赁服务行业中，整体跌幅为1.23%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113044925971a61d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113044925971a61d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4022","CAR","BK4230"],"gpt_icon":0},{"id":"2482575242","title":"BUZZ-前瞻：赫兹股价上涨，租车公司将再报亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=2482575242","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482575242?lang=zh_cn&edition=full","pubTime":"2024-11-12 03:44","pubTimestamp":1731354251,"startTime":"0","endTime":"0","summary":"    11月11日 - ** 赫兹全球控股  股价上涨4.7%，报3.30美元，周一连续第七个交易日上涨，周二开盘前将发布第三季度报告。** 在过去的 8 个季度中，HTZ 有 6 次达到或超过了一致预期，而有一半的时间达到或超过了亏损预期。该公司在之前的 3 份季报中均出现亏损。** 在需求疲软的情况下，赫兹  一直在瘦身，在维修和车队维护费用高于预期后，清理了电动汽车。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","HTZ","CAR","BK4585","BK4230"],"gpt_icon":0},{"id":"2482085812","title":"市场规模超三百亿美元 细胞基因治疗仍有多重关卡待闯","url":"https://stock-news.laohu8.com/highlight/detail?id=2482085812","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482085812?lang=zh_cn&edition=full","pubTime":"2024-11-11 17:08","pubTimestamp":1731316115,"startTime":"0","endTime":"0","summary":"继小分子和大分子靶向疗法之后，细胞基因治疗（CGT）正在成为最新一代精准医疗手段，以传统药物难以比拟的长期疗效和治愈潜力，为治疗肿瘤、罕见病、慢性疾病以及其他难以治愈的疾病带来了创新的理念和方法。各类重磅政策相继出台支持CGT产业发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202411113235799327.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411113235799327.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4230","CAR","BK4022"],"gpt_icon":0},{"id":"2482494062","title":"吉利德：砍掉三条管线，CAR-T大卖35亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482494062","media":"生物药大时代","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482494062?lang=zh_cn&edition=full","pubTime":"2024-11-11 10:50","pubTimestamp":1731293459,"startTime":"0","endTime":"0","summary":"截至2024年9月30日，吉利德公司的现金、现金等价物和有价债务证券为50.37亿美元，而截至2023年12月31日为84亿美元。吉利德重新调整了全年业绩指引，将其产品总销售预期上调至278-281亿美元，高于此前的271-275亿美元。其中Yescarta 2024 Q3销售额3.87亿美元，同比下降1%，环比下降7%；CD19 CAR-T疗法Tecartus2024Q3销售额0.98亿美元，同比增长2%，环比下降8%。吉利德砍掉三条管线。吉利德公司表示将进一步调查这些数据，但拒绝回答有关死亡的问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111105229abb47233&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111105229abb47233&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LU1571399168.USD","BK4588","LU2087621335.USD","LU2468319806.SGD","IE00BKVL7J92.USD","LU0320765992.SGD","LU1585245621.USD","LU0058720904.USD","IE00BZ1G4Q59.USD","BK4583","IE00B19Z3581.USD","CAR","IE00BSNM7G36.USD","LU0109394709.USD","BK4022","LU0289739699.SGD","LU1066053197.SGD","LU1430594728.SGD","BK4578","BK4139","BK4230","IE00B19Z3B42.SGD","BK4532","LU0889565916.HKD","GILD","BK4568","IE0002270589.USD","LU0234570918.USD","LU1839511570.USD","BK4566","BK4550","LU1066051498.USD"],"gpt_icon":1},{"id":"2482124861","title":"港股异动 | 科济药业-B(02171)再涨超10% CT0590通用型CAR-T细胞疗法安全性可控 市场潜力巨大","url":"https://stock-news.laohu8.com/highlight/detail?id=2482124861","media":"智通财经","labels":["Product Release","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482124861?lang=zh_cn&edition=full","pubTime":"2024-11-11 09:53","pubTimestamp":1731290013,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，科济药业-B再涨超10%，截至发稿，涨9.92%，报8.3港元，成交额8296.87万港元。其中，CT0590研究初步结果表明，CT0590通用型CAR-T细胞疗法的安全性可控，同时实现了深度和持久的临床缓解。科济药业表示，与自体CAR-T相比，通用型CAR-T的成本将大大降低，且因其“货供应”的特点，患者等待时间缩短，将极大程度提高CAR-T的可及性，突破现有细胞治疗的行业瓶颈，具有巨大的市场潜力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209042.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"Product Release,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK4022","BK4230","CAR","BK1585","BK1587","02171","BK1574"],"gpt_icon":1},{"id":"2482442213","title":"安飞士2024财年第三财季实现净利润2.37亿美元，同比减少62.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482442213","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482442213?lang=zh_cn&edition=full","pubTime":"2024-11-10 00:00","pubTimestamp":1731168039,"startTime":"0","endTime":"0","summary":"11月10日，安飞士公布财报，公告显示公司2024财年第三财季净利润为2.37亿美元，同比减少62.14%；其中营业收入为34.80亿美元，同比减少2.36%，每股基本收益为6.68美元。从资产负债表来看，安飞士总负债329.78亿美元，其中短期债务11.23亿美元，资产负债比为1.00，流动比率为0.70。机构评级：截至2024年11月10日，当前有9家机构对安飞士目标价做出预测，其中目标均价为124.22美元，其中最低目标价为85.00美元，最高目标价为160.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000057a22784ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000057a22784ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAR"],"gpt_icon":0},{"id":"2482652482","title":"安飞士盘中异动 大幅下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482652482","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482652482?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:43","pubTimestamp":1731084225,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日00时43分，安飞士股票出现异动，股价快速下跌5.00%。截至发稿，该股报90.05美元/股，成交量11.2682万股，换手率0.32%，振幅4.58%。机构评级方面，在所有10家参与评级的机构中，70%的券商给予买入建议，30%的券商给予持有建议，无券商给予卖出建议。安飞士股票所在的租赁服务行业中，整体涨幅为0.26%。安飞士公司简介：Avis Budget Group Inc 是一家汽车租赁和汽车共享服务提供商。公司品牌包括 Avis、Budget 和 Zipcar。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109004345abae8ba4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109004345abae8ba4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAR","BK4230","BK4022"],"gpt_icon":0},{"id":"2481296631","title":"进博观察｜创新药械如何克服落地障碍？中外企业多方协作打通“最后一公里”","url":"https://stock-news.laohu8.com/highlight/detail?id=2481296631","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481296631?lang=zh_cn&edition=full","pubTime":"2024-11-08 17:58","pubTimestamp":1731059888,"startTime":"0","endTime":"0","summary":"随着医疗行业的迅猛发展和创新成果的不断涌现，新药和高质量医疗设备的普及不仅需要“可获得性”，还必须确保“可负担性”和“合理使用”。目前，国家医疗保险的基本原则是广泛覆盖和保障基本需求。近年来，在政策的推动下，更多真正需要的创新药品被及时纳入基本医疗保险的报销范围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202411083234191733.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411083234191733.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4230","CAR","BK1574","BK4022","06978","BK1161"],"gpt_icon":0},{"id":"2481139162","title":"科济药业-B早盘涨逾22% 通用型CAR-T产品CT0590临床数据亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=2481139162","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481139162?lang=zh_cn&edition=full","pubTime":"2024-11-08 09:50","pubTimestamp":1731030600,"startTime":"0","endTime":"0","summary":"　　科济药业-B早盘继续走高，该股昨日收涨逾41%，两个交易日累涨八成。截至发稿，股价上涨21.92%，现报8.18港元，成交额1.29亿港元。　　科济药业此前宣布其产品赛恺泽、CT071和CT0590的数据将在第66届美国血液学会年会上以壁报形式展示，会议将于12月7日至10日举行。科济药业靶向BCMA的通用型CAR-T产品CT0590的首个人体一期试验中，共入组5名受试者，中位随访时间16.6个月。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-11-08/doc-incvihkr2205219.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-11-08/doc-incvihkr2205219.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","BK1587","02171","BK4230","CAR","BK1585","BK4022","BK1574"],"gpt_icon":0},{"id":"2481169229","title":"港股异动 | 科济药业-B(02171)再涨超26% 两日股价累涨八成 通用型CAR-T产品CT0590临床数据亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=2481169229","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481169229?lang=zh_cn&edition=full","pubTime":"2024-11-08 09:34","pubTimestamp":1731029663,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，科济药业-B再涨超26%，该股昨日收涨逾41%，两个交易日累涨八成。截至发稿，涨26.23%，报8.47港元，成交额7178.34万港元。消息面上，科济药业此前宣布其产品赛恺泽、CT071和CT0590的数据将在第66届美国血液学会年会上以壁报形式展示，会议将于12月7日至10日举行。科济药业靶向BCMA的通用型CAR-T产品CT0590的首个人体一期试验中，共入组5名受试者，中位随访时间16.6个月。其中3例患者获得缓解，包括2例严格完全缓解和1例部分缓解。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208308.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK4230","CAR","BK4022","BK1587","02171","BK1161","BK1585"],"gpt_icon":0},{"id":"2481943280","title":"港股异动 | 科济药业-B(02171)午后一度涨超46% 通用型CAR-T产品CT0590临床数据亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=2481943280","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481943280?lang=zh_cn&edition=full","pubTime":"2024-11-07 13:52","pubTimestamp":1730958765,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，科济药业-B午后一度涨超46%，截至发稿，涨33.19%，报6.3港元，成交额2.77亿港元。其中，科济药业靶向BCMA的通用型CAR-T CT0590首次人体I期试验数据显示，共入组5例受试者，中位随访时间为16.6个月时，有3例患者获得缓解。包括2例sCR和1例PR。在这2例sCR患者中，CAR拷贝数峰值大于280,000 copies/g genomic DNA。研究的初步结果表明，CT0590通用型CAR-T细胞疗法的安全性可控，同时实现了深度和持久的临床缓解。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1207878.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1587","BK4022","CAR","BK1161","02171","BK4230","BK1585"],"gpt_icon":0},{"id":"2481948727","title":"【港股通】科济药业(02171)午后升逾27% CT0590通用型CAR-T细胞疗法的安全性可控","url":"https://stock-news.laohu8.com/highlight/detail?id=2481948727","media":"金吾财讯","labels":["Product Release","Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481948727?lang=zh_cn&edition=full","pubTime":"2024-11-07 13:28","pubTimestamp":1730957295,"startTime":"0","endTime":"0","summary":"金吾财讯 | 科济药业(02171)午后涨幅扩大，截至发稿，涨27.27%，报6.02港元，成交额1.55亿港元。日前公司宣布将在第66届美国血液学会年会上通过海报形式展示赛恺泽（泽沃基奥仑赛注射液）、CT071和CT0590的研究数据，该会议定于2024年12月7日至10日举行。这些产品的摘要已发布在ASH官方网站上。其中，CT0590研究初步结果表明，CT0590通用型CAR-T细胞疗法的安全性可控，同时实现了深度和持久的临床缓解。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/MDI1YTMwZTQxYzhhNDE2OTgwYTUxYmYyODYyMzUwODkzNDM3NDk5.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MDI1YTMwZTQxYzhhNDE2OTgwYTUxYmYyODYyMzUwODkzNDM3NDk5.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1947283","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release,Business Data","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1161","YANG","BK1574","HSCEI","BK4022","BK1585","HSTECH","CAR","BK4230","02171"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.avisbudgetgroup.com","stockEarnings":[{"period":"1week","weight":-0.0462},{"period":"1month","weight":0.2761},{"period":"3month","weight":0.1561},{"period":"6month","weight":-0.0918},{"period":"1year","weight":-0.4541},{"period":"ytd","weight":-0.4266}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Avis Budget Group, Inc.是一家在特拉华州成立，总部位于新泽西州帕西帕尼市的公司。艾维士·巴吉集团为全球企业和消费者提供汽车和卡车租赁和配套服务。该公司经营着两家全球汽车租赁行业中最知名的品牌Avis和Budget。 Avis是一家领先的汽车租赁供应商，定位于服务旅游业的优质商业和休闲领域，而Budget是一家领先的汽车租赁供应商，业务主要集在该行业中更具价值意识的部分。该公司是领先的汽车租赁运营商，在北美，澳大利亚，新西兰和其他地区都有业务服务，该公司授权在世界各地以Avis和Budget品牌经营的国家就有超过180个多个。该公司通常在机场汽车租赁收入中占有主要份额，并运营着美国主要的卡车租赁业务之一。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.012765},{"month":2,"riseRate":0.642857,"avgChangeRate":0.055699},{"month":3,"riseRate":0.642857,"avgChangeRate":0.042142},{"month":4,"riseRate":0.642857,"avgChangeRate":0.012091},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.006618},{"month":6,"riseRate":0.5,"avgChangeRate":0.008098},{"month":7,"riseRate":0.571429,"avgChangeRate":0.042418},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.005429},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.030283},{"month":10,"riseRate":0.714286,"avgChangeRate":0.13912},{"month":11,"riseRate":0.714286,"avgChangeRate":0.075638},{"month":12,"riseRate":0.461538,"avgChangeRate":-0.03046}],"exchange":"NASDAQ","name":"安飞士","nameEN":"Avis Budget"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安飞士(CAR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安飞士(CAR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安飞士,CAR,安飞士股票,安飞士股票老虎,安飞士股票老虎国际,安飞士行情,安飞士股票行情,安飞士股价,安飞士股市,安飞士股票价格,安飞士股票交易,安飞士股票购买,安飞士股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安飞士(CAR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安飞士(CAR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}